CleanMargins, Inc. is a newly formed subsidiary of pHLIP, Inc. Our fluorescent agent, MarginVue, is being used to intraoperatively assess surgical margins in real time, to allow surgeons to detect and remove positive margins during breast conserving cancer surgery. MarginVue has shown no side effects, and has high sensitivity and specificity, while exhibiting none of the shortcomings of other approaches. We are in late Phase 2 trials at MSKCC together with Stryker, and seek a lead investor for a series A round of $5M.